001     120023
005     20240228135007.0
024 7 _ |a 10.1158/2159-8290.CD-13-0349
|2 doi
024 7 _ |a pmid:24356097
|2 pmid
024 7 _ |a pmc:PMC4134522
|2 pmc
024 7 _ |a 2159-8274
|2 ISSN
024 7 _ |a 2159-8290
|2 ISSN
024 7 _ |a altmetric:2135604
|2 altmetric
037 _ _ |a DKFZ-2017-00611
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Oakes, Christopher C
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia.
260 _ _ |a Philadelphia, Pa.
|c 2014
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1490701717_15175
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Although clonal selection by genetic driver aberrations in cancer is well documented, the ability of epigenetic alterations to promote tumor evolution is undefined. We used 450k arrays and next-generation sequencing to evaluate intratumor heterogeneity and evolution of DNA methylation and genetic aberrations in chronic lymphocytic leukemia (CLL). CLL cases exhibit vast interpatient differences in intratumor methylation heterogeneity, with genetically clonal cases maintaining low methylation heterogeneity and up to 10% of total CpGs in a monoallelically methylated state. Increasing methylation heterogeneity correlates with advanced genetic subclonal complexity. Selection of novel DNA methylation patterns is observed only in cases that undergo genetic evolution, and independent genetic evolution is uncommon and is restricted to low-risk alterations. These results reveal that although evolution of DNA methylation occurs in high-risk, clinically progressive cases, positive selection of novel methylation patterns entails coevolution of genetic alteration(s) in CLL.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Claus, Rainer
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Gu, Lei
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Assenov, Yassen
|0 P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c
|b 3
|u dkfz
700 1 _ |a Hüllein, Jennifer
|0 P:(DE-He78)c9be4ab60d1090c3d315a2ca6905e9ea
|b 4
|u dkfz
700 1 _ |a Zucknick, Manuela
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Bieg, Matthias
|0 P:(DE-He78)e247efc0264a7b0e4bae09804002d4e1
|b 6
|u dkfz
700 1 _ |a Brocks, David
|0 P:(DE-He78)3860e24c3868c15255c3383a58e8d5b8
|b 7
|u dkfz
700 1 _ |a Bogatyrova, Olga
|0 P:(DE-He78)3493620cedb8f0b17c9e1b424c0e21db
|b 8
|u dkfz
700 1 _ |a Schmidt, Christopher R
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Rassenti, Laura
|b 10
700 1 _ |a Kipps, Thomas J
|b 11
700 1 _ |a Mertens, Daniel
|0 P:(DE-He78)833c06a995d272b78f3a20df3eba6e9e
|b 12
|u dkfz
700 1 _ |a Lichter, Peter
|0 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
|b 13
|u dkfz
700 1 _ |a Döhner, Hartmut
|b 14
700 1 _ |a Stilgenbauer, Stephan
|b 15
700 1 _ |a Byrd, John C
|b 16
700 1 _ |a Zenz, Thorsten
|0 P:(DE-He78)f3d5f16b49eb47520def635be98d5576
|b 17
|u dkfz
700 1 _ |a Plass, Christoph
|0 P:(DE-He78)4301875630bc997edf491c694ae1f8a9
|b 18
|e Last author
|u dkfz
773 _ _ |a 10.1158/2159-8290.CD-13-0349
|g Vol. 4, no. 3, p. 348 - 361
|0 PERI:(DE-600)2607892-2
|n 3
|p 348 - 361
|t Cancer discovery
|v 4
|y 2014
|x 2159-8290
909 C O |o oai:inrepo02.dkfz.de:120023
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)45a6854ecf41ba2e65ca3ba0d560f14c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)c9be4ab60d1090c3d315a2ca6905e9ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)e247efc0264a7b0e4bae09804002d4e1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)3860e24c3868c15255c3383a58e8d5b8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)3493620cedb8f0b17c9e1b424c0e21db
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)833c06a995d272b78f3a20df3eba6e9e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)f3d5f16b49eb47520def635be98d5576
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)4301875630bc997edf491c694ae1f8a9
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2014
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER DISCOV : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b CANCER DISCOV : 2015
920 1 _ |0 I:(DE-He78)C010-20160331
|k C010
|l Epigenomik und Krebsrisikofaktoren
|x 0
920 1 _ |0 I:(DE-He78)B080-20160331
|k B080
|l Theoretische Bioinformatik
|x 1
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 2
920 1 _ |0 I:(DE-He78)B060-20160331
|k B060
|l Molekulare Genetik
|x 3
920 1 _ |0 I:(DE-He78)G100-20160331
|k G100
|l Translationale Onkologie
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C010-20160331
980 _ _ |a I:(DE-He78)B080-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)B060-20160331
980 _ _ |a I:(DE-He78)G100-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21